| Product NDC: | 0703-2856 | 
| Proprietary Name: | Propofol | 
| Non Proprietary Name: | Propofol | 
| Active Ingredient(s): | 10 mg/mL & nbsp; Propofol | 
| Administration Route(s): | INTRAVENOUS | 
| Dosage Form(s): | INJECTION, EMULSION | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 0703-2856 | 
| Labeler Name: | Teva Parenteral Medicines, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA075102 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20070621 | 
| Package NDC: | 0703-2856-04 | 
| Package Description: | 25 VIAL, SINGLE-USE in 1 TRAY (0703-2856-04) > 20 mL in 1 VIAL, SINGLE-USE (0703-2856-01) | 
| NDC Code | 0703-2856-04 | 
| Proprietary Name | Propofol | 
| Package Description | 25 VIAL, SINGLE-USE in 1 TRAY (0703-2856-04) > 20 mL in 1 VIAL, SINGLE-USE (0703-2856-01) | 
| Product NDC | 0703-2856 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | Propofol | 
| Dosage Form Name | INJECTION, EMULSION | 
| Route Name | INTRAVENOUS | 
| Start Marketing Date | 20070621 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Teva Parenteral Medicines, Inc. | 
| Substance Name | PROPOFOL | 
| Strength Number | 10 | 
| Strength Unit | mg/mL | 
| Pharmaceutical Classes | General Anesthesia [PE],General Anesthetic [EPC] |